Innovative Device R&D Integration Service Platform

Service Creates Value

Learn more

Leading Medical Device CRO in China with Global Reach

Global Excellence, China Expertise

Learn more

Integration Service Platform for In Vitro Diagnostic Product

R&D, Quality System, Clinical Evaluation, Marketing Application, Post-marketing Support

Learn more
20 +

Years of Corporate History

180 +

Global Offices

1900 +

Global Clients

200 +

Products Registration Support Annually

Our Services

Providing Medical Devices Full Lifecycle CRO Services

As the leading medical device CRO in China,Tigermed-Jyton offers the full life cycle service and global expertise in all stages of the product development process. With our rich project experience and strong professionalism, our dedicated team is committed to offering optimized solutions that aim fast-track commercialization of your product, reducing project risks while achieving cost-efficient outcomes.


Tigermed-Jyton has accumulated a large customer base and rich product experience while assisting in developing some products with cutting-edge technologies. We have provided services to many medical device companies and established advantages in multiple areas including oncology, orthopedics, cardiovascular, ophthalmology, medical aesthetics, artificial intelligence, stomatology, and more. 


News

Tigermed-Jyton Announces Acquisition of NAMSA China and Global Strategic Partnership with NAMSA

BEIJING, CHINA and TOLEDO, US –February 29, 2024—Tigermed-Jyton, a leading medical device CRO in China, and NAMSA, a global leader MedTech Contract Research Organization (CRO) offering global end-to-end development services, today announced Tigermed-Jyton’s acquisition of NAMSA China, as well as the exclusive China region partnership and global collaboration between Tigermed-Jyton and NAMSA.

TOP
Contacts
Cookies
The site uses cookies in order to collect data to provide general statistics to optimize site functionality and offer you a better experience. For more information, visit our Privacy Policy.